⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEM News
Tempus AI, Inc. Class A Common Stock
Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”
businesswire.com
TEM
Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes
businesswire.com
TEM
Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
businesswire.com
TEM
Form 8-K
sec.gov
TEM
Tempus to Host Inaugural Investor Day on May 29, 2026
businesswire.com
TEM
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026
businesswire.com
TEM
Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights
businesswire.com
TEM
Median Technologies publie ses résultats financiers annuels 2025 et présente les principaux faits marquants du premier trimestre 2026
businesswire.com
TEM
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026
businesswire.com
TEM
BMY
Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care
businesswire.com
TEM